new icn messageflickr-free-ic3d pan white
Study Participant Receives NIAID/GSK Candidate Ebola Vaccine | by NIAID
Back to photostream

Study Participant Receives NIAID/GSK Candidate Ebola Vaccine

September 2, 2014 — A 39-year-old woman, the first participant enrolled in VRC 207, receives a dose of the investigational NIAID/GSK Ebola vaccine at the NIH Clinical Center in Bethesda, Md. Credit: NIAID

32,897 views
5 faves
0 comments
Taken on September 2, 2014